solriamfetol   Click here for help

GtoPdb Ligand ID: 10342

Synonyms: ADX-N05 | ADXN05 | JZP-110 | JZP110 | Sunosi®
Approved drug
solriamfetol is an approved drug (FDA (2019), EMA (2020))
Compound class: Synthetic organic
Comment: Solriamfetol is a norepinephrine-dopamine reuptake inhibitor that was developed by Jazz Pharmaceuticals [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 78.34
Molecular weight 194.11
XLogP 0.49
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NC(Cc1ccccc1)COC(=O)N
Isomeric SMILES N[C@H](Cc1ccccc1)COC(=O)N
InChI InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1
InChI Key UCTRAOBQFUDCSR-SECBINFHSA-N
Selectivity at transporters
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
NET Hs Inhibitor Inhibition 5.4 pKi - 1
pKi 5.4 (Ki 3.7x10-6 M) [1]
Description: In a radioligand binding assay using HEK293 cells expressing hNET.
DAT Hs Inhibitor Inhibition 4.8 pKi - 1
pKi 4.8 (Ki 1.42x10-5 M) [1]
Description: In a radioligand binding assay using HEK293 cells expressing hDAT.
DAT Hs Inhibitor Inhibition 5.5 pIC50 - 1
pIC50 5.5 (IC50 2.9x10-6 M) [1]
Description: In a DA reuptake assay in HEK293 cells expressing hDAT.
NET Hs Inhibitor Inhibition 5.4 pIC50 - 1
pIC50 5.4 (IC50 4.4x10-6 M) [1]
Description: In a NE reuptake assay in HEK293 cells expressing hNET.